MENU CLOSE

News

Gateway to the Brain

Your gateway to company updates, events, and our latest research milestones

scroll

Our Latest News

  • Events

Welcome to the Future of the Brain-Nose Interface!

We’re bringing together scientists, clinicians, and innovators from around the world for a one-day deep dive into one of the most exciting emerging topics in neuroscience and medicine: the Brain-Nose Interface (BNI). We are exploring the direct link between the nose and the brain – with exiting implication for diagnostics, therapeutics and interdisciplinary science.
Read more
  • News

Noselab GmbH Showcases Revolutionary Diagnostic Platform for Neurodegenerative Diseases at 2024 AD/PD Conference in Lisbon

Following Noselab´s successful presentations at CTAD 2023 and the BioCapital Europe Investor Conference, we are all set to showcase our innovative diagnostic platform at the highly anticipated 2024 AD/PD Conference in Lisbon, Portugal. Learn more about Noselab’s pioneering work at AD/PD 2024, where we unveil our groundbreaking diagnostic platform!
Read more
  • Events

Noselab Goes AD/PD™ 2024

Be part of our journey as we join the esteemed AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases! Visit us in Lisbon from March 5th to 9th, 2024. At our booth (#19) we will present our revolutionary diagnostic platform approach based on nasal-derived CSF (nCSF) and related research milestones.
Read more
  • News
  • Events

Noselab GmbH Unveils Revolutionary Diagnostic Platform for Neurodegenerative Diseases at 2024 BioCapital Europe Investor Conference

At the esteemed 2024 BioCapital Europe Investor Conference, Noselab GmbH made waves with its revolutionary diagnostic breakthrough. CEO Thomas Heydler revealed their groundbreaking proprietary diagnostic platform, aiming to transform the lives of patients with neurodegenerative diseases (ND), with an initial focus on Alzheimer’s Disease.
Read more